Adrenal incidentalomas: Risk of adrenocortical carcinoma and clinical outcomes

Journal of Surgical Oncology

Volumn 102, Issue 5, 2010, Pages 450-453

  O'Neill, Christine J ^a   Spence, Andrew ^a   Logan, Barney ^a   Suliburk, James W ^a   Soon, Patsy S ^b   Learoyd, Diana L ^c   Sidhu, Stan B ^a,b   Sywak, Mark S ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

Adrenalectomy; Adrenocortical adenoma; Adrenocortical carcinoma; Incidental findings; Pathology; Surgical

Indexed keywords

ADRENAL CORTEX CARCINOMA; ADRENAL INCIDENTALOMA; ADRENALECTOMY; ADULT; AGED; ARTICLE; CANCER RISK; CLINICAL FEATURE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INCIDENTAL FINDING; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; ADOLESCENT; ADRENAL CORTEX NEOPLASMS; ADRENOCORTICAL CARCINOMA; KAPLAN MEIER METHOD; MIDDLE AGED; PATHOLOGY; RISK; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADRENAL CORTEX NEOPLASMS; ADRENALECTOMY; ADRENOCORTICAL CARCINOMA; ADULT; AGED; HUMANS; INCIDENTAL FINDINGS; KAPLAN-MEIERS ESTIMATE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK; TREATMENT OUTCOME; YOUNG ADULT; KAPLAN-MEIER ESTIMATE;

EID: 77957341739     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21553     Document Type: Article

References (21)

1. Young WF, Jr.: Clinical practice. The incidentally discovered adrenal mass. N Engl J Med 2007;356:601-610.
2. Grumbach MM, Biller BM, Braunstein GD, et al.: Management of the clinically inapparent adrenal mass ("incidentaloma"). Ann Intern Med 2003;138:424-429. (Pubitemid 36262654)
3. Sidhu S, Sywak M, Robinson B, et al.: Adrenocortical cancer: Recent clinical and molecular advances. Curr Opin Oncol 2004;16:13-18. (Pubitemid 38703466)
4. Mantero F, Terzolo M, Arnaldi G, et al.: A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab 2000;85:637-644.
5. Barzon L, Boscaro M: Diagnosis and management of adrenal incidentalomas. J Urol 2000;163:398-407.
6. Brunt LM, Moley JF: Adrenal incidentaloma. World J Surg 2001;25:905-913.
7. Libe R, Dall'Asta C, Barbetta L, et al.: Long-term follow-up study of patients with adrenal incidentalomas. Eur J Endocrinol 2002;147:489-494. (Pubitemid 35238144)
8. Sidhu SB, Bambach CP, Pillinger SH, et al.: Changing pattern of adrenalectomy at a tertiary referral centre 1970-2000. ANZ J Surg 2002;72:463-466.
9. Pillinger SH, Bambach CP, Sidhu S: Laparoscopic adrenalectomy: A 6-year experience of 59 cases. ANZ J Surg 2002;72:467-470. (Pubitemid 34779373)
10. Soon PS, McDonald KL, Robinson BG, et al.: Molecular markers and the pathogenesis of adrenocortical cancer. Oncologist 2008;13:548-561. (Pubitemid 351872872)
11. Mansmann G, Lau J, Balk E, et al.: The clinically inapparent adrenal mass: Update in diagnosis and management. Endocr Rev 2004;25:309-340. (Pubitemid 38528713)
12. Soon PS, Yeh MW, Delbridge LW, et al.: Laparoscopic surgery is safe for large adrenal lesions. Eur J Surg Oncol 2008;34:67-70. (Pubitemid 350296763)
13. Boland GW, Blake MA, Hahn PF, et al.: Incidental adrenal lesions: Principles, techniques, and algorithms for imaging characterization. Radiology 2008;249:756-775.
14. Barzon L, Sonino N, Fallo F, et al.: Prevalence and natural history of adrenal incidentalomas. Eur J Endocrinol 2003;149:273-285. (Pubitemid 37304697)
15. Kasperlik-Zaluska AA, Otto M, Cichocki A, et al.: 1,161 patients with adrenal incidentalomas: Indications for surgery. Langenbecks Arch Surg 2008;393:121-126.
16. Allolio B, Fassnacht M: Clinical review: Adrenocortical carcinoma: Clinical update. J Clin Endocrinol Metab 2006;91:2027-2037. (Pubitemid 43854976)
17. Weiss LM, Medeiros LJ, Vickery AL: Pathologic features of prognostic significance in adrenocortical carcinoma. Am J Surg Pathol 1989;13:202-206. (Pubitemid 19081702)
18. Assie G, Antoni G, Tissier F, et al.: Prognostic parameters of metastatic adrenocortical carcinoma. J Clin Endocrinol Metab 2007;92:148-154. (Pubitemid 46067523)
19. Giordano T, Kuick R, Else T: Molecular classification and prognostication of adrenocortical tumours by transcriptome profiling. Clin Cancer Res 2009;15:668-676.
20. de Reynies A, Assie G, Rickman DS, et al.: Gene expression profiling reveals a new classification of adrenocortical tumors and identifies molecular predictors of malignancy and survival. J Clin Oncol 2009;27:1108-1115.
21. Soon P, Gill A, Benn D, et al.: Microarray gene expression and immunohistochemistry analyses of adrenocortical tumours identify IGF2 and Ki-67 as useful in differentiating carcinomas from adenomas. Endocr Relat Cancer 2009;16:573-583.